Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Prostatic acid phosphatase is expressed in human prostate cancer bone metastases and promotes osteoblast differentiation.

Kirschenbaum A, Liu XH, Yao S, Leiter A, Levine AC.

Ann N Y Acad Sci. 2011 Nov;1237:64-70. doi: 10.1111/j.1749-6632.2011.06198.x.

PMID:
22082367
2.

Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.

Yang J, Fizazi K, Peleg S, Sikes CR, Raymond AK, Jamal N, Hu M, Olive M, Martinez LA, Wood CG, Logothetis CJ, Karsenty G, Navone NM.

Cancer Res. 2001 Jul 15;61(14):5652-9.

3.

Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.

Fizazi K, Yang J, Peleg S, Sikes CR, Kreimann EL, Daliani D, Olive M, Raymond KA, Janus TJ, Logothetis CJ, Karsenty G, Navone NM.

Clin Cancer Res. 2003 Jul;9(7):2587-97.

4.

Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases.

Kirschenbaum A, Izadmehr S, Yao S, O'Connor-Chapman KL, Huang A, Gregoriades EM, Yakar S, Levine AC.

Endocrinology. 2016 Dec;157(12):4526-4533. Epub 2016 Oct 26.

PMID:
27783536
5.

Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment.

Larson SR, Chin J, Zhang X, Brown LG, Coleman IM, Lakely B, Tenniswood M, Corey E, Nelson PS, Vessella RL, Morrissey C.

Clin Exp Metastasis. 2014 Feb;31(2):247-56. doi: 10.1007/s10585-013-9625-2. Epub 2013 Nov 17.

6.

Prostate-specific antigen induces apoptosis of osteoclast precursors: potential role in osteoblastic bone metastases of prostate cancer.

Goya M, Ishii G, Miyamoto S, Hasebe T, Nagai K, Yonou H, Hatano T, Ogawa Y, Ochiai A.

Prostate. 2006 Nov 1;66(15):1573-84.

PMID:
16927388
7.

Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity.

Kitagawa Y, Dai J, Zhang J, Keller JM, Nor J, Yao Z, Keller ET.

Cancer Res. 2005 Dec 1;65(23):10921-9.

8.

Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein.

Dai J, Kitagawa Y, Zhang J, Yao Z, Mizokami A, Cheng S, Nör J, McCauley LK, Taichman RS, Keller ET.

Cancer Res. 2004 Feb 1;64(3):994-9.

9.

Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone.

Li ZG, Yang J, Vazquez ES, Rose D, Vakar-Lopez F, Mathew P, Lopez A, Logothetis CJ, Lin SH, Navone NM.

Oncogene. 2008 Jan 24;27(5):596-603. Epub 2007 Aug 13.

PMID:
17700537
10.

Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2.

Nadiminty N, Lou W, Lee SO, Mehraein-Ghomi F, Kirk JS, Conroy JM, Zhang H, Gao AC.

Clin Cancer Res. 2006 Mar 1;12(5):1420-30. Erratum in: Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3552.

11.

Osteoblast-secreted collagen upregulates paracrine Sonic hedgehog signaling by prostate cancer cells and enhances osteoblast differentiation.

Zunich SM, Valdovinos M, Douglas T, Walterhouse D, Iannaccone P, Lamm ML.

Mol Cancer. 2012 Jul 13;11:30. doi: 10.1186/1476-4598-11-30.

12.

Prostate cancer cells promote osteoblastic bone metastases through Wnts.

Hall CL, Bafico A, Dai J, Aaronson SA, Keller ET.

Cancer Res. 2005 Sep 1;65(17):7554-60.

13.

Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism.

Dai J, Keller J, Zhang J, Lu Y, Yao Z, Keller ET.

Cancer Res. 2005 Sep 15;65(18):8274-85.

14.

The effect of cyclooxygenase-2 (COX-2) inhibition on human prostate cancer induced osteoblastic and osteolytic lesions in bone.

Gamradt SC, Feeley BT, Liu NQ, Roostaeian J, Lin YQ, Zhu LX, Sharma S, Dubinett SM, Lieberman JR.

Anticancer Res. 2005 Jan-Feb;25(1A):107-15.

16.

Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.

Feeley BT, Gamradt SC, Hsu WK, Liu N, Krenek L, Robbins P, Huard J, Lieberman JR.

J Bone Miner Res. 2005 Dec;20(12):2189-99. Epub 2005 Aug 1.

17.

[Mechanism of osteoblastic bone metastasis of prostate cancer].

Yonou H, Ogawa Y, Ochiai A.

Clin Calcium. 2006 Apr;16(4):557- 64. Review. Japanese.

PMID:
16582505
18.

[Is skeletal alkaline phosphatase a valid staging marker in detection of osteoblastic skeletal metastases of prostate carcinoma?].

Wirtz DC, Wolff JM, Ittel TH, Jakse G, Niethard FU.

Z Orthop Ihre Grenzgeb. 1998 May-Jun;136(3):255-9. German.

PMID:
9736988
19.

Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss.

Wakchoure S, Swain TM, Hentunen TA, Bauskin AR, Brown DA, Breit SN, Vuopala KS, Harris KW, Selander KS.

Prostate. 2009 May 1;69(6):652-61. doi: 10.1002/pros.20913.

PMID:
19152406
20.

Supplemental Content

Support Center